+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-color FISH in 54 patients with therapy-related MDS/AML

Multi-color FISH in 54 patients with therapy-related MDS/AML

Blood 98(11 Part 1): 579a, November 16

In therapy-related MDS/AML (t-MDS/t-AML) 80-90% of the patients (pts.) present chromosome aberrations, which in 20-30% cannot be fully identified by conventional G-banding. Bone marrow cells were investigated by multi-color FISH (M-FISH) in 11 pts. with t-MDS/t-AML and a normal karyotype and in 43 pts. with one or more unidentified chromosome aberrations. Dual-color FISH with whole chromosome painting probes and centromere-specific probes were subsequently applied to confirm the results of M-FISH. No new abnormalities were detected in 11 pts. with t-MDS/t-AML and a normal karyotype. Chromosome 5 was involved in 23/43 pts. with previously unidentified aberrations, in all cases resulting in loss of various parts of, or of the whole long arm of the chromosome. Chromosome 7 was involved in 17/43 pts. with previously unidentified chromosome aberrations, in 14/43 resulting in loss of various parts of, or of the whole long arm of the chromosome. Only 2/15 pts. still presented monosomy 5, and only 6/14 pts. presented monosomy 7 after M-FISH. Chromosome 3 was involved in 16/43 pts. with unidentified aberrations, chromosome 6 in 10/43 pts., and chromosome 11 in 10/43 pts. The abnormalities of chromosome 11 resulted in gain of various parts of 11q in all 10 pts., whereas the abnormalities of chromosomes 3 and 6 were uncharacteristic. Only 1/43 pts. with previously unidentified aberrations showed a balanced translocation, a t(3;9). The breakpoints of this particular case is under investigation. Dicentric chromosomes were suggested by M-FISH and confirmed by centromere-specific probes in 19/43 pts. with previously unidentified aberrations. Formation of dicentrics resulted in loss of 5q in 12 pts, loss of 7q in 5 pts., and loss of 17p in 5 pts., whereas chromosome 18 was involved in 4 cases. Thus, the frequency of dicentric chromosomes in t-MDS/t-AML is even higher than previously reported. In conclusion, M-FISH is very useful as a supplement to G-banding in pts. with unidentified chromosome aberrations, but is of limited value in pts. with a normal karyotype.

(PDF 0-2 workdays service: $29.90)

Accession: 035349040

Download citation: RISBibTeXText

Related references

Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH. Lupus 16(12): 955-962, 2007

Detection of -7 and +8 by interphase FISH in myeloid malignant hemopathies Comparison of one-color with dual-color FISH and study of 3 patients. Cytogenetics & Cell Genetics 77(1-2): 129, 1997

Detection of chromosomal abnormalities with multi-color fluorescence in situ hybridization (M-FISH) imaging and multi-spectral wavelet analysis. Conference Proceedings 2008: 1222-1225, 2009

Chromosome aberrations and aneuploidy in sperm of Hodgkins disease patients before and approximately 15 years after MOPP-chemotherapy analyzed by multi-color fish. Environmental & Molecular Mutagenesis 29(SUPPL 28): 53, 1997

A simple G-banding technique adaptable for fluorescent in situ hybridization (FISH) and physical ordering of human renin (REN) and cathepsin E (CTSE) genes by multi-color FISH. Acta Histochemica et Cytochemica 26(4): 319-324, 1993

Multi-color FISH techniques. Current Protocols in Cell Biology Chapter 22: Unit 22.5-Unit 22.5, 2008

Multi-color CD34⁺ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia. Leukemia Research 36(8): 974-981, 2012

Standard dose of idarubicin and cytarabine is highly effective remission induction therapy for the patients with therapy-related leukemia A result of multi-institutional phase II study. Blood 94(10 SUPPL 1 PART 1): 298a, Nov 15, 1999

Chromosome 13 deletion using tri-color FISH in multiple myeloma Lack of prognostic implications in patients receiving total therapy II. Blood 96(11 Part 1): 548a, November 16, 2000

Multi-color FISH to study mosaicism for X chromosome aneuploidy. American Journal of Human Genetics 59(4 SUPPL ): A114, 1996

Classification of renal cell carcinomas by multi-color fish. Journal of Urology 171(4 Supplement): 467, April, 2004

Multi-color fish for improved detection of bladder cancer. Acta Cytologica 46(1 Supplement): 100, January-February, 2002

Dysmorphic features, extra chromosome material and multi-color FISH. American Journal of Human Genetics 71(4 Supplement): 303, October, 2002

Multi-color fish for improved detection of urothelial carcinoma in urinary specimens. Pathology Research & Practice 197(5): 360, 2001

Multi-color FISH for enhanced detection of urothelial carcinoma in urinary specimens. Journal of Urology 165(5 Supplement): 162, 2001